RIA Advisory Group »

Regeneron Pharmaceuticals shares owned by RIA Advisory Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by RIA Advisory Group from 13F filings

Historical chart of RIA Advisory Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by RIA Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by RIA Advisory Group

Quarter filed Position value Share count Share price at filing
2023-03-31 $431k 524 821.67
2022-12-31 $391k 542 721.53

More positions owned by RIA Advisory Group

Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Blackrock Ultra (ICSH)
Vanguard World Fds Utilities Etf (VPU)
IDEXX Laboratories (IDXX)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Walt Disney Company (DIS)
Medifast (MED)
Realreal (REAL)
Proshares Tr K1 Fre Crd Oil (OILK)
Invesco Exchange Traded Fd T S&p500 Eql Hlt (RSPH)
Ishares Silver Tr Ishares (SLV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Associated Banc- (ASB)

View all positions for RIA Advisory Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Bank of New York Mellon
Amundi
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals